Nearly everyone has focused on Aurora Cannabis‘ (NYSE:ACB) great opportunity in the Canadian recreational marijuana market. The company has gotten off to a pretty good start with that opportunity, capturing a 20% market share in its latest quarter.But nearly everyone also knows that Aurora’s future rides largely on international medical marijuana markets. The largest of these international opportunities right now is Germany. On Tuesday, Aurora Cannabis announced that it had begun selling cannabis oils to German pharmacies. It’s a milestone that should mean that higher revenue and profit margins are on the way.